Cargando…
A Unified Proteochemometric Model for Prediction of Inhibition of Cytochrome P450 Isoforms
A unified proteochemometric (PCM) model for the prediction of the ability of drug-like chemicals to inhibit five major drug metabolizing CYP isoforms (i.e. CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4) was created and made publicly available under the Bioclipse Decision Support open source system at w...
Autores principales: | Lapins, Maris, Worachartcheewan, Apilak, Spjuth, Ola, Georgiev, Valentin, Prachayasittikul, Virapong, Nantasenamat, Chanin, Wikberg, Jarl E. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684587/ https://www.ncbi.nlm.nih.gov/pubmed/23799117 http://dx.doi.org/10.1371/journal.pone.0066566 |
Ejemplares similares
-
Origin of aromatase inhibitory activity via proteochemometric modeling
por: Simeon, Saw, et al.
Publicado: (2016) -
Proteochemometric modeling of HIV protease susceptibility
por: Lapins, Maris, et al.
Publicado: (2008) -
Proteochemometric Modeling of the Susceptibility of Mutated Variants of the HIV-1 Virus to Reverse Transcriptase Inhibitors
por: Junaid, Muhammad, et al.
Publicado: (2010) -
Linking the Resource Description Framework to cheminformatics and proteochemometrics
por: Willighagen, Egon L, et al.
Publicado: (2011) -
Data mining for the identification of metabolic syndrome status
por: Worachartcheewan, Apilak, et al.
Publicado: (2018)